Products

Primary tabs

Export products to Excel

Displaying 46 - 60 of 209
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Vas Deferens
Project Stage: Lead Optimization
Partner: Contraline, LLC
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Pre-clinical
Partner: Bayer HealthCare
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Hormonal
Delivery Type: Oral
Project Stage: Marketed
Partner: HRA Pharma
Development Status: Limited Market Approval
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Gel, Vaginal, Other
Project Stage: Pre-clinical
Partner: Viramal Limited
Alternative Name: Merck Vaginal Ring MK-8342B
Development Status: Inactive
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase III
Partner: Merck
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Pre-clinical
Alternative Name: EP007
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Pre-clinical
Alternative Name: Estetrol (E4) + Progestin Combined Pill
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Oral
Project Stage: Phase II
Partner: Actavis
Alternative Name: EVE-106; EVE106; ethinylestradiol prodrugs
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: TBD
Project Stage: Pre-clinical
Partner: Evestra, Inc.
Alternative Name: Etonogestrel (ENG) + ethinylestradiol (EE) vaginal ring; EVE112
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase II
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Partner: Evestra, Inc.
Development Status: Limited Market Approval
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Marketed
Partner: Famy Care Ltd.
Alternative Name: Antiestrogen ICI 182780, Fulvestrant
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Pre-clinical
Partner:
Export to Excel